Edition:
India

Luye Pharma Group Ltd (2186.HK)

2186.HK on Hong Kong Stock

5.09HKD
9:03am IST
Change (% chg)

HK$0.09 (+1.80%)
Prev Close
HK$5.00
Open
HK$5.00
Day's High
HK$5.13
Day's Low
HK$4.98
Volume
4,324,607
Avg. Vol
15,988,959
52-wk High
HK$5.80
52-wk Low
HK$3.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1,850.78 0.117
FY 2016 Dec '16 1,428.72 0.141
Jun '16 1,489.07 0.128
FY 2015 Dec '15 812.41 0.111
Jun '15 1,750.72 0.116
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 14 3,616.73 3,810.12 3,335.92 3,322.41
Year Ending Dec-18 14 3,957.35 4,275.81 3,705.00 3,826.03
Earnings (per share)
Year Ending Dec-17 16 0.29 0.37 0.24 0.31
Year Ending Dec-18 16 0.33 0.39 0.28 0.36
LT Growth Rate (%) 2 13.51 19.10 7.91 21.39
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.59 31.14 32.93
P/E High - Last 5 Yrs. 39.54 40.91 45.62
P/E Low - Last 5 Yrs. 15.34 23.80 24.34
Beta -- 0.90 0.88
Price to Sales (TTM) 4.07 3.93 5.40
Price to Book (MRQ) 2.08 4.81 5.38
Price to Tangible Book (MRQ) 2.94 5.53 6.78
Price to Cash Flow (TTM) 13.05 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) 24.95 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 24.29 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 42.49 4.66 5.38
Sales - 5 Yr. Growth Rate 10.46 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.17 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 7.97 -- --
EPS - 5 Yr. Growth Rate -2.69 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -1.16 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.56 2.11 2.18
Current Ratio (MRQ) 1.67 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 49.50 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 77.76 55.14 54.83
Gross Margin - 5 Yr. Avg. 82.18 52.29 52.40
EBITD Margin (TTM) 32.22 -- --
EBITD - 5 Yr. Avg 28.96 18.46 15.24
Operating Margin (TTM) 30.02 14.50 7.76
Operating Margin - 5 Yr. Avg. 26.60 14.42 10.75
Pre-Tax Margin (TTM) 28.82 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 25.54 14.74 11.17
Net Profit Margin (TTM) 26.19 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 21.91 11.08 7.47
Effective Tax Rate (TTM) 9.13 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 14.22 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,102,350 953,213,828 864,673,362
Net Income/Employee (TTM) 288,658 112,151,383 101,717,513
Receivable Turnover (TTM) 4.42 5.60 5.76
Inventory Turnover (TTM) 1.89 2.58 3.34
Asset Turnover (TTM) 0.33 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.55 11.42 11.00
Return on Assets - 5 Yr. Avg. 11.07 13.00 12.43
Return on Investment (TTM) 13.25 14.86 14.46
Return on Investment - 5 Yr. Avg. 14.87 17.00 16.28
Return on Equity (TTM) 13.61 16.28 16.05
Return on Equity - 5 Yr. Avg. 15.47 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 13.84 5.07 10.46
EPS (TTM) % 18.16 31.89 -2.69
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Luye Pharma Group Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.86%
# of Holders: 86
Total Shares Held: 460,303,337
3 Mo. Net Change: -16,144,904
# New Positions: 3
# Closed Positions: 8
# Increased Positions: 17
# Reduced Positions: 15
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.